FDA-Approved Small Molecules in 2022: Clinical Uses and Their Synthesis

This review describes the recently FDA-approved drugs (in the year 2022). Many of these products contain active moieties that FDA had not previously approved, either as a single ingredient or as part of a combination. These products frequently provide important new therapies for patients with multip...

Descripción completa

Detalles Bibliográficos
Autores principales: Benedetto Tiz, Davide, Bagnoli, Luana, Rosati, Ornelio, Marini, Francesca, Santi, Claudio, Sancineto, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695118/
https://www.ncbi.nlm.nih.gov/pubmed/36432728
http://dx.doi.org/10.3390/pharmaceutics14112538

Ejemplares similares

Ejemplares similares